Health Care & Life Sciences » Pharmaceuticals | Vicore Pharma Holding AB

Vicore Pharma Holding AB

Vicore Pharma Holding AB
Stock Exchange First North Sweden
EPS
SEK0.51
Market Cap
SEK308.64 M
Shares Outstanding
15.87 M
Public Float
-

Profile

Address
Bioventurehub
Mölndal VG 431 83
Sweden
Employees -
Website http://www.vicorepharma.com
Updated 09/14/2018
Vicore Pharma Holding AB is a drug development company, which engages in the development of molecules. It designs, synthesizes, and patents a collection of small non-peptide molecules including anti-inflammation, nerve generation and cardiovascular disease. The company was founded in 2005 and is headquartered in Molndal, Sweden.

Financials

View All
Created with Highcharts 5.0.14Vicore Pharma Holding ABNet Income. Fiscal year is January-December. All values SEK Thousands.1 6031 60313 68713 6874 5704 5706 6526 65212 85512 8552013201420152016201702.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14Vicore Pharma Holding ABSales/Revenue. Fiscal year is January-December. All values SEK Thousands.00008408408528529329322013201420152016201702505007501000

Leif E. Darner
Chairman
Peter Jan Sture Ström
Director